Declining gastrointestinal opportunistic infections in HIV-infected persons: A triumph of science and a challenge for our HAARTs and minds

American Journal of Gastroenterology

Volumn 100, Issue 7, 2005, Pages 1455-1458

  Raufman, Jean Pierre ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANDIDA ALBICANS; CANDIDIASIS; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBSTANCE ABUSE; T LYMPHOCYTE; UNITED NATIONS; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; GASTROINTESTINAL DISEASES; HIV INFECTIONS; HUMANS; INCIDENCE;

EID: 22744442068     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50088.x     Document Type: Review

References (15)

1. Mocroft A, Oancea C, van Lunzen J, et al. Decline in esophageal candidiasis and use of antimyocotics in European patients with HIV. Am J Gastroenterol 2005; 100.
2. Anonymous. Pneumocystis pneumonia-Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2.
3. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
4. Raufman JP, Straus EW. Gastrointestinal endoscopy in patients with acquired immune deficiency syndrome: An evaluation of current practices. Gastrointest Endosc 1987;33:76-9.
5. Shuts R. And the band played on. New York: St. Martin's Press, 1987.
6. Tavitian A, Raufman JP, Rosenthal LE. Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:54-5.
7. Raufman JP. Odynophagia/dysphagia in AIDS. Gastroenterol Clin North Am 1988;17:599-614.
8. Xie Q, Raufman JP. Esophageal infections. In: Schlossberg D, ed. Current therapy of infectious disease, 2nd Ed. St. Louis: Mosby, 2001;167-73.
9. Farman J, Tavitian A, Rosenthal LE, et al. Focal esophageal candidiasis in acquired immunodeficiency syndrome (AIDS). Gastrointest Radiol 1986;11:213-7.
10. Tavitian A, Raufman JP, Rosenthal LE, et al. Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 1986;90:443-5.
11. Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial. Ann Intern Med 1992;117:655-60.
12. Kearney D, McDonald G. Esophageal disorders caused by infection, systemic illness, medications, radiation, and trauma. In: Feldman M, Friedman LS, Sleisenger MH, et al, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management, 7th Ed, Vol 1. Philadelphia: W B Saunders, 2002;623-46.
13. Farah CS, Elahi S, Drysdale K, et al. Primary role for CD4(+) T lymphocytes in recovery from oropharyngeal candidiasis. Infect Immun 2002;70:724-31.
14. Monkemuller KE, Call SA, Lazenby AJ, et al. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol 2000;95:457-62.
15. Anonymous. World Population Prospects: The 2000 Revision Highlights, 2001 United Nations Population Division.